跳至主要内容
临床试验/NCT01750320
NCT01750320已完成1 期

Koning Breast CT-guided Biopsy Phase I Trial

Koning Corporation2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2012年8月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
4
试验地点
2
主要终点
The accuracy of Koning breast CT-guided biopsy

研究概览

简要总结

The primary aim of this study is to show that the accuracy of Koning Breast CT-guided biopsy is at least equivalent to that of stereotactic-guided biopsy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female at least 35 years of age of any ethnicity
  • Lesion seen on mammography
  • Diagnostic report read as BI-RADS 4 or 5
  • Will undergo biopsy no later than four weeks from date of mammogram
  • Is able to undergo informed consent

排除标准

  • Pregnancy
  • Lactation
  • Subjects with breast implants
  • Subjects with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pacemaker.
  • Subjects who are unable to tolerate study constraints.
  • Subjects who have received radiation treatments to the thorax for malignant and nonmalignant conditions, such as (but not limited to)
  • Treatment for enlarged thymus gland as an infant
  • Irradiation for benign breast conditions, including breast inflammation after giving birth
  • Treatment for Hodgkins disease
  • Subjects who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram.
  • Subjects who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as (but not limited to)
  • Tuberculosis
  • Severe scoliosis

研究组 & 干预措施

Koning Breast CT - guided Biopsy

Experimental

干预措施: Koning Breast CT-guided Biopsy (Device)

结局指标

主要结局

The accuracy of Koning breast CT-guided biopsy

时间窗: about 1 year

The goal of this study is to evaluate the concordance of Koning Breast CT-guided Biopsy (KBCT-GBx) results to diagnostic work-up imaging (at least mammographic) and KBCT imaging and to verify that the localization and guidance accuracy of KBCT-GBx is at least equivalent to stereotactic-guided biopsy to validate the localization and guidance accuracy of KBCT-GBx.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验